| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1172 | 2020 |
| Persistence and evolution of SARS-CoV-2 in an immunocompromised host B Choi, MC Choudhary, J Regan, JA Sparks, RF Padera, X Qiu, ... New England Journal of Medicine 383 (23), 2291-2293, 2020 | 1145 | 2020 |
| 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis L Fraenkel, JM Bathon, BR England, EW St. Clair, T Arayssi, K Carandang, ... Arthritis & Rheumatology 73 (7), 1108-1123, 2021 | 1005 | 2021 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 649 | 2021 |
| 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases LR Sammaritano, BL Bermas, EE Chakravarty, C Chambers, MEB Clowse, ... Arthritis & rheumatology 72 (4), 529-556, 2020 | 600 | 2020 |
| Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children PY Lee, M Day-Lewis, LA Henderson, KG Friedman, J Lo, JE Roberts, ... The Journal of clinical investigation 130 (11), 5942-5950, 2020 | 388 | 2020 |
| Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’ KM D’Silva, N Serling-Boyd, R Wallwork, T Hsu, X Fu, EM Gravallese, ... Annals of the rheumatic diseases 79 (9), 1156-1162, 2020 | 306 | 2020 |
| Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden M Neovius, JF Simard, J Askling, ARTIS Study Group Annals of the rheumatic diseases 70 (4), 624-629, 2011 | 270 | 2011 |
| Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study B Lu, LT Hiraki, JA Sparks, S Malspeis, CY Chen, JA Awosogba, ... Annals of the rheumatic diseases 73 (11), 1914-1922, 2014 | 265 | 2014 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 260 | 2023 |
| A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19 AHJ Kim, JA Sparks, JW Liew, MS Putman, F Berenbaum, ... Annals of internal medicine 172 (12), 819-821, 2020 | 255 | 2020 |
| Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden P Raaschou, JF Simard, M Holmqvist, J Askling Bmj 346, 2013 | 252 | 2013 |
| Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries MA Gianfrancesco, KL Hyrich, L Gossec, A Strangfeld, L Carmona, ... The Lancet Rheumatology 2 (5), e250-e253, 2020 | 243 | 2020 |
| Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab M Neovius, EV Arkema, H Olsson, JK Eriksson, LE Kristensen, JF Simard, ... Annals of the rheumatic diseases 74 (2), 354-360, 2015 | 235 | 2015 |
| Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis A Finckh, JF Simard, C Gabay, PA Guerne Annals of the rheumatic diseases 65 (6), 746-752, 2006 | 232 | 2006 |
| Incidence of rheumatoid arthritis in Sweden: a nationwide population‐based assessment of incidence, its determinants, and treatment penetration JK Eriksson, M Neovius, S Ernestam, S Lindblad, JF Simard, J Askling Arthritis care & research 65 (6), 870-878, 2013 | 226 | 2013 |
| 2015 American College of Rheumatology workforce study: supply and demand projections of adult rheumatology workforce, 2015–2030 DF Battafarano, M Ditmyer, MB Bolster, JD Fitzgerald, C Deal, AR Bass, ... Arthritis care & research 70 (4), 617-626, 2018 | 222 | 2018 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 212 | 2021 |
| Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study JT Gustafsson, JF Simard, I Gunnarsson, K Elvin, IE Lundberg, ... Arthritis research & therapy 14, 1-11, 2012 | 198 | 2012 |
| Predictors of the first cardiovascular event in patients with systemic lupus erythematosus-a prospective cohort study J Gustafsson, I Gunnarsson, O Börjesson, S Pettersson, S Möller, GZ Fei, ... Arthritis research & therapy 11, 1-11, 2009 | 194 | 2009 |
